Transient activation of the UPR


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
04 2019
Historique:
received: 08 11 2018
accepted: 25 02 2019
entrez: 17 4 2019
pubmed: 17 4 2019
medline: 6 5 2020
Statut: epublish

Résumé

Somatic cells can be reprogrammed into pluripotent stem cells using the Yamanaka transcription factors. Reprogramming requires both epigenetic landscape reshaping and global remodeling of cell identity, structure, basic metabolic processes, and organelle form and function. We hypothesize that variable regulation of the proteostasis network and its influence upon the protein-folding environment within cells and their organelles is responsible for the low efficiency and stochasticity of reprogramming. We find that the unfolded protein response of the endoplasmic reticulum (UPR

Identifiants

pubmed: 30989118
doi: 10.1126/sciadv.aaw0025
pii: aaw0025
pmc: PMC6457941
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaaw0025

Subventions

Organisme : NIA NIH HHS
ID : R01 AG042679
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA196884
Pays : United States

Références

Eur J Cell Biol. 2016 Mar-May;95(3-5):115-23
pubmed: 26905505
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8
pubmed: 18287077
Cell Stem Cell. 2008 Feb 7;2(2):151-9
pubmed: 18371436
Nature. 2012 Sep 13;489(7415):304-8
pubmed: 22972301
Cell. 2016 Sep 8;166(6):1539-1552.e16
pubmed: 27610574
Nat Rev Genet. 2013 Jun;14(6):427-39
pubmed: 23681063
Nat Cell Biol. 2015 Jun;17(6):715-25
pubmed: 25985393
Nat Commun. 2013;4:1382
pubmed: 23340422
Science. 2006 Jul 7;313(5783):104-7
pubmed: 16825573
PLoS One. 2007 Jun 27;2(6):e571
pubmed: 17593970
Mol Cell. 2007 Jul 6;27(1):53-66
pubmed: 17612490
Cell. 2012 Dec 21;151(7):1617-32
pubmed: 23260147
Stem Cells Dev. 2007 Feb;16(1):167-76
pubmed: 17348812
Mol Cell. 2012 Sep 28;47(6):827-38
pubmed: 23020854
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Nat Rev Drug Discov. 2013 Sep;12(9):703-19
pubmed: 23989796
J Biol Chem. 2012 Nov 23;287(48):40767-78
pubmed: 23019325
Trends Cell Biol. 2011 Dec;21(12):709-17
pubmed: 21900009
Nature. 2012 Mar 04;483(7391):598-602
pubmed: 22388813
Cell. 2001 Dec 28;107(7):881-91
pubmed: 11779464
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11269-74
pubmed: 15277680
Nat Biotechnol. 2009 Nov;27(11):1033-7
pubmed: 19826408
Cell. 2012 Nov 21;151(5):994-1004
pubmed: 23159369
Science. 2011 Nov 25;334(6059):1081-6
pubmed: 22116877
Trends Cell Biol. 2014 Mar;24(3):161-70
pubmed: 24094931
Cell Stem Cell. 2012 Dec 7;11(6):783-98
pubmed: 23103054
Mol Biol Cell. 1999 Nov;10(11):3787-99
pubmed: 10564271
Nature. 1999 Jan 21;397(6716):271-4
pubmed: 9930704
Cancer Discov. 2015 Jun;5(6):586-97
pubmed: 25977222
Nat Methods. 2011 May;8(5):409-12
pubmed: 21460823
Biochem Biophys Res Commun. 2007 Apr 6;355(2):543-8
pubmed: 17307147
Nat Rev Mol Cell Biol. 2016 Mar;17(3):183-93
pubmed: 26883003
Nature. 2002 Jan 3;415(6867):92-6
pubmed: 11780124
Nature. 2008 Jul 3;454(7200):49-55
pubmed: 18509334
Cell Stem Cell. 2008 Sep 11;3(3):346-353
pubmed: 18786421
Nat Biotechnol. 2011 Jul 07;29(8):731-4
pubmed: 21738127

Auteurs

Milos S Simic (MS)

Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
California Institute for Regenerative Medicine, Berkeley, CA 94720, USA.
University of California, Berkeley, Berkeley, CA 94720, USA.

Erica A Moehle (EA)

Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
California Institute for Regenerative Medicine, Berkeley, CA 94720, USA.
University of California, Berkeley, Berkeley, CA 94720, USA.

Robert T Schinzel (RT)

Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
California Institute for Regenerative Medicine, Berkeley, CA 94720, USA.
University of California, Berkeley, Berkeley, CA 94720, USA.

Franziska K Lorbeer (FK)

University of California, Berkeley, Berkeley, CA 94720, USA.

Jonathan J Halloran (JJ)

Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
California Institute for Regenerative Medicine, Berkeley, CA 94720, USA.
University of California, Berkeley, Berkeley, CA 94720, USA.

Kartoosh Heydari (K)

University of California, Berkeley, Berkeley, CA 94720, USA.

Melissa Sanchez (M)

Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
California Institute for Regenerative Medicine, Berkeley, CA 94720, USA.
University of California, Berkeley, Berkeley, CA 94720, USA.

Damien Jullié (D)

University of California, San Francisco, San Francisco, CA 94143, USA.

Dirk Hockemeyer (D)

University of California, Berkeley, Berkeley, CA 94720, USA.

Andrew Dillin (A)

Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
California Institute for Regenerative Medicine, Berkeley, CA 94720, USA.
University of California, Berkeley, Berkeley, CA 94720, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH